In Indonesia, home to the world’s second-largest TB burden, a USAID program that supported national TB elimination across four provinces serving 145 million people was terminated. Plans to expand drug-resistant TB (DR-TB) services were frozen, leaving roughly 60% of DR-TB cases undetected.
Date: 10/25
Region: East Asia & Pacific
Country: Indonesia
Topic: Health
Policy Lens: Global Health Security
Additional Context: Indonesia has the second highest TB burden in the world. USAID Bersama Menuju Eliminasi dan Bebas dari TB (BEBAS-TB) was a five-year flagship project that strove to work collaboratively with national and international stakeholders to support the Government of Indonesia in achieving its goal to eliminate TB by 2030, focused primarily on four provinces with high TB burdens: North Sumatra, West Java, Central Java, and East Java. The closure directly puts 145,000 high-risk individuals, including TB contacts, people with HIV, diabetes, and prison populations, at risk of going untreated, and an estimated 80,000 people will miss preventive therapy. The resulting resurgence threatens not only Indonesians but regional and global TB-control progress.
Source: MSH

